Crossmark

Anti-inflammatory effects of 4- o -methyl-benzenesulfonyl benzoxazolone (MBB) in vivo and in vitro as a novel NSAIDs lead compound

Crossref DOI link: https://doi.org/10.1016/j.pharep.2017.12.002

Published Print: 2018-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tang, Li

Luo, Jie-ran

Li, Dai-tian

Ge, Rui

Ma, Yun-long

Xu, Fei

Liang, Tai-gang

Ban, Shu-rong

Li, Qing-shan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81602976)

Shanxi Province Foundation for Returness (2014-2)

Science and Technology Innovation Project of Shanxi Province (2014132, 2015150)

Shanxi Province Science Foundation for Youths (201601D021159)

Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province (2016)

Research Project Supported by Shanxi Scholarship Council of China (2017-061)

Doctoral Scientific Research Foundation of Shanxi Medical University (03201319, 03201320)
License Information

Text and Data Mining valid from 2018-06-01
More Information

This article is maintained by: Elsevier

Article Title: Anti-inflammatory effects of 4-o-methyl-benzenesulfonyl benzoxazolone (MBB) in vivo and in vitro as a novel NSAIDs lead compound

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2017.12.002

Content Type: article

Copyright: © 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.